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Pretransplant donor biopsy (PTDB)-based marginal
donor allocation systems to single or dual renal
transplantation could increase the use of organs with
Kidney Donor Profile Index (KDPI) in the highest range
(e.g. >80 or >90), whose discard rate approximates
50% in the United States. To test this hypothesis, we
retrospectively calculated the KDPI and analyzed the
outcomes of 442 marginal kidney transplants (340
single transplants: 278 with a PTDB Remuzzi score <4
[median KDPI: 87; interquartile range (IQR): 78–94] and
62 with a score¼ 4 [median KDPI: 87; IQR: 76–93]; 102
dual transplants [median KDPI: 93; IQR: 86–96]) and 248
single standard transplant controls (median KDPI: 36;
IQR: 18–51). PTDB-based allocation of marginal grafts
led to a limited discard rate of 15% for kidneys with
KDPI of 80–90 and of 37% for kidneyswith a KDPI of 91–
100. Although 1-year estimated GFRs were significan-
tly lower in recipients of marginal kidneys (9.3,17.9
and18.8mL/min, for dual transplants, single kidneys
with PTDB score <4 and ¼4, respectively; p<0.001),
graft survival (median follow-up 3.3 years) was similar
between marginal and standard kidney transplants
(hazard ratio: 1.20 [95% confidence interval: 0.80–1.79;
p¼ 0.38]). In conclusion, PTDB-based allocation allows
the safe transplantation of kidneys with KDPI in the
highest range that may otherwise be discarded.
Abbreviations: CI, confidence interval; DUAL, dual
kidney transplant; ECD, expanded criteria donor; eCrCl,
estimated creatinine clearance; eGFR, estimated GFR;
HR, hazard ratio; IQR, interquartile range; KDPI, Kidney
Donor Profile Index; KDRI, Kidney Donor Risk Index;
OPTN, Organ Procurement and Transplantation Net-
work; PTDB, pretransplant donor biopsy; SINGLE Sc.
< 4, single kidney transplant with PTDB yielding a
score< 4; SINGLE Sc.¼ 4, single kidney transplant
with PTDB yielding a score¼ 4; STANDARD, standard
criteria donor kidney transplant; UNOS, UnitedNetwork
Organ Sharing
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Introduction
The increasing number of patients on the waiting lists for
kidney transplantation has not been paralleled by a similar
growth in the number of available donors (1). More
worrisome is the fact that over 20% of available kidneys
are from donors who are older than 65 years, or have
diabetes or renal impairment, and are therefore frequently
not considered suitable for donation, due to the increased
risk of early failure of their organs (2–4).
In the United States, despite the implementation of the
expanded criteria donor (ECD) program over 10 years ago,
the percentage of kidneys recovered but not transplanted
remains over 40%. Major determinants of discard rates are
biopsy findings on wedge biopsy (percent glomeruloscle-
rosis) and parameters of machine pump perfusion (5). The
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United Network of Organ Sharing (UNOS) Kidney Trans-
plantation Committee has recently approved a new alloca-
tion policy, that will be implemented by the end of 2014 (6),
which is based on the Kidney Donor Risk Index (KDRI), that
represents the relative risk of posttransplant graft failure
from a particular deceased donor compared to the average
donor (7). The Kidney Donor Profile Index (KDPI) is an
additional numerical score, which results from ranking KDRI
from the 1st to the 100th percentile, with reference to a
given Organ Procurement and Transplantation Network
(OPTN) donor cohort. Among organs retrieved between
2002 and 2012, 36% and 63% of kidneys with KDPI 80–90
and >90 were discarded, respectively (4).
Starting with the rationale that poor long-term outcome of
marginal grafts is the consequence of an imbalance
between the number of viable nephrons supplied, and
the metabolic demand of the recipient (8), a standardized
assessment of pretransplant donor biopsies (PTDBs) has
been proposed to estimate nephron mass. This estimate
allows discrimination between kidneys that would provide
outcomes similar to standard organs and those that should
be discarded (9). Histological evaluation can also identify
kidneys with suboptimal nephron mass that should not be
transplanted alone, but may be suitable if used in dual
transplantation.
Although the histological criteria to allocate grafts to single
or dual transplantation or to discard them are still not
uniform (10–17,18), there is evidence suggesting that this
strategy might help in recovering marginal kidneys which
would be otherwise discarded, without affecting patient
outcomes (11,12,19,20).
The aimof the present studywas to test the hypothesis that
a standardized PTDB assessment-based allocation ap-
proach allows identification of kidneys with KDPI in the
highest range that are suitable for single or dual transplan-
tation. To this end, we examined the KDPI distribution and
outcomes of 442 marginal kidneys allocated to single or
dual transplantation exclusively on the basis of a standard-
ized assessment of PTDB.We also included in our analyses
248 control recipients of single standard kidney transplants.
Materials and Methods
Study population
Recipients of marginal kidney transplants: We included all patients
who received a single or dual kidney transplant between 2001 and 2009 from
deceased donors after a standardized assessment of PTDB for the purpose
of organ allocation at the Organ Procurement Organization of the Emilia
Romagna Region, Italy. The Organ Procurement Organization serves the
kidney transplant centers of Parma, Bologna and Modena. Indication for
PTDB included donor age 65 years, renal dysfunction (estimated
creatinine clearance [eCrCl] <60mL/min), or proteinuria >1 g/day. Donors
evaluated by standardized assessment of PTDB will be referred to as
marginal donors.
Recipients of dual transplants: Not all candidate recipients of a single
kidney transplant were deemed suitable to receive dual transplantation and,
due to the increased surgical risk, they had to sign an ad hoc informed
consent at the time ofwaitlisting. Recipients of dual transplantswere usually
55 years or older, had not received prior transplants, had acceptable aorto-
iliac vessels and adequate dimensions of the abdominal cavity allowing
placement of two renal grafts. Patients regarded at increased perioperative
risk because of coronary heart disease were usually not deemed suitable for
receiving a dual transplantation. Dual kidneys were placed in the iliac fossa
unilaterally or bilaterally at the discretion of the surgeon.
Standardized assessment of PTDB and kidney allocation: Kidneys
were used for single or dual transplant, or were discarded, exclusively on the
basis of PTDB results, regardless of the donor’s clinical characteristics (9).
Small, punch-biopsies, preferentially taken before aortic clamping, were
sent to the centralized pathology laboratory at theMalpighi Hospital, Bologna
and read within 3–4 h upon arrival by well-trained on-call pathologists.
Permanent formalin-fixed sections were stained with hematoxylin and
eosin, periodic acid-Schiff, Masson’s trichrome and periodic acid-methena-
mine Silver. Each kidney structure (vessels, glomeruli, tubules and
connective tissue) was scored from 0 (no changes) to 3 (marked changes)
according to Remuzzi et al (9). The scores of each structure were summed
up yielding a final score ranging from 0 to 12 per kidney. Kidneys with final
score <4 were allocated as single transplants, and those with score 4–6
were allocated as dual transplants.When the sum of the left and right kidney
scorewas above 12, kidneyswere discarded. Since February 2005, because
of changes in allocation policy, kidneys with score 4 were systematically
used as single transplants. As a result, the proportion of PTDB-based
allocation to single transplant with score¼ 4 increased from 9.2% to 19.7%.
Nonetheless, the proportion of dual transplants also increased (from 11.3%
to 17.4%).
Recipients of standard kidney transplants: As controls, we included all
consecutive kidney transplant patients who received, between 2001 and
2013, a single deceased-donor kidney transplant at the Transplant Center of
Parma, who had not undergone standardized assessment of PTDB and did
not fulfill the clinical criteria used to define the ECD program in the United
States (21). These donors will be referred to as standard donors.
Allocation system: Allocation of every suitable kidney (single or dual) was
based on a dedicated software algorithm, which prioritized the level of HLA
matching, donor–recipient age matching (highest score if 10 years, worse
if 20 years) and time on the waiting list (22).
Data collection
In October 2007, an ad hoc database was established to investigate
strategies to improve the allocation of marginal donors (Emilia-Romagna
Program Region-University [P.R.U.] 2007–2009 ‘‘expansion strategies for
the donor pool in solid organ transplantation’’). Donors’ clinical and
histopathological data were extracted from the Organ Procurement
Organization database, and recipients’ data were extracted from the clinical
charts of the three transplant Centers (Bologna, Modena and Parma). Data
collection was accomplished in two stages: retrospectively for transplants
performed in the period February 2001–November 2006, and prospectively,
on a reduced version of the same database, for the transplants performed
during the period between January 2007 and December 2009. Hence, the
follow-up period never exceeded 5 years. Data on standard controls were
retrospectively collected in 2013 at the Parma Transplant Center and
included all consecutive transplants performed from 2001 to 2013. They
were extracted from the clinical charts, and from the database implemented
at the same Center for routine clinical care.
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We computed the KDPI using the open source calculator (available at: http://
optn.transplant.hrsa.gov/resources/allocationcalculators.asp?index¼81) (23)
that is based on the 2010 OPTN deceased-donor cohort. The KDPI is the
percentile rank (from the 1st the 100th) of the KDRI with reference to a given
OPTN deceased-donor cohort. The KDRI represents the relative risk of
posttransplant graft failure from a particular deceased donor compared to the
donor in the 50th percentile of risk,with the recipient characteristics being set
to thepopulation average values (17). TheKDRI scoring systemwasbasedon
10 deceased-donor variables (age, weight, height, creatinine, ethnicity,
hypertension, diabetes, cause of death, HCV-positive donor and donation
after cardiovascular death), with no donor having either of latter two
characteristics (7).
GFR was estimated according to the four-variable MDRD formula (24).
Albuminuria was defined as >300mg/g urinary creatinine or equivalent
definition. Systolic and diastolic blood pressures refer to office blood
pressure measurements taken during routine visits. Delayed graft function
was defined as the need for dialysis during the first week after
transplantation. We documented all cases of acute clinical rejection,
defined by deterioration in graft function and histopathological changes,
according to the consensus rules of the international Banff classification
criteria (25).
Statistical analysis
All analyses were performed using the statistical package Stata Statistical
Software package, Release 12.0. (StataCorp, College Station, TX). A two-
tailed p-value less than 0.05 was regarded as statistically significant unless
otherwise stated.
We tested for any difference across the four categories using Kruskal–Wallis
equality-of-populations rank test for continuous variables, and Fisher’s exact
test for categorical variables. Pairwise comparisons (Mann–Whitney test, or
Fisher’s exact test) were performed whenever p< 0.05. To allow for
multiple testing, only pairwise comparisons with p< 0.01 were reported as
statistically significant.
We used the Kaplan–Meier method to estimate the crude probability of
uncensored and death-censored graft survival and the log-rank test to test
the equality of survivor functions. We used Cox regression models to
examine the multivariable-adjusted relationship between transplant categ-
ory, KDPI and graft failure.
With regard to the analysis of longitudinal (i.e. repeated measures)
variables such as estimated GFR (eGFR), systolic and diastolic blood
pressure, we used repeated measures linear mixed models using
restricted maximum likelihood to account for the presence of unbalanced
data (26,27). We used random coefficient regression models to estimate
changes over time in the presence of unbalanced data (26). The
prevalence of albuminuria (coded as an indicator variable 1 if yes, 0 if
otherwise) was examined by multiple logistic regression using general-
ized estimating equations with robust standard errors to account for
repeated measurements in each patient (28). Multivariable-adjusted
regression models included the following recipient characteristics:
recipient age and gender, cold ischemia time, dialysis vintage, body
weight, height, HLA mismatch level (29), re-transplant, induction
treatment (indicator variates for basiliximab and Thymoglobulins) and
type of calcineurin inhibitor (indicator variates for cyclosporine instead of
tacrolimus). Predicted survival, eGFR, and proteinuria and their confi-
dence intervals (CIs) were calculated from predictions of the previously fit
model at fixed values of the covariates.
A more detailed description of the statistical analysis is provided in the
Supplementary Methods.
Results
Characteristics of discarded donor kidneys
Between November 2001 and December 2012, out of a
total of 1479 potential kidney donor offers in the Organ
Procurement Organization of the three transplant centers,
182 (12.3%)were discarded.Only 37 of them (20.3%)were
discarded because of a high histological score (1.8%of total
donor offers). The discard rate was 14.9% (95%CI: 9.1–
23.5) and 36.8% (95%CI: 30.3–43.9) among donors with
KDPI 80–90, and KDPI 91–100, respectively. The median
KDPI in the kidneys discarded of unfavorable PTDB findings
was 95 (interquartile range [IQR]: 87–97), similar to the
KDPI of the kidneys discarded for clinical reasons (median
94 [IQR: 80–98], p¼ 0.89). eCrCl and eGFR were also
similar between kidneys discarded after PTDB versus the
others (mean [SD] of eCrCl: 63.9 [21.1] vs. 66.5 [29.5],
p¼ 0.96; mean [SD] of eGFR 71.2 [22.2] vs. 75.6 [29.2],
p¼ 0.41).
Characteristics of the kidney transplant population
Donor characteristics: The study population included
248 kidney transplants from standard criteria donors
(‘‘STANDARD transplant’’) and 442 kidney transplants
from marginal donors evaluated by a standardized assess-
ment of PTDB: 102 dual transplants (‘‘DUAL transplant’’),
278 single kidney transplants with PTDB yielding a score
< 4 (‘‘SINGLE Sc.<4 transplant’’) and 62 single kidney
transplants with PTDB yielding a score¼ 4 (‘‘SINGLE
Sc.¼ 4 transplant’’). Compared with donors of STANDARD
transplants, marginal donors died significantly more often
of cerebrovascular disease (p< 0.01 for all pairwise
comparisons), were significantly older, more often diabetic,
hypertensive and had worse renal function (Table 1). Not all
marginal donors fulfilled the definition of ECD (Table 1).
Cold ischemia time was slightly shorter in STANDARD
transplants compared with the other three categories.
DUAL transplants, SINGLE Sc.< 4 transplants and SINGLE
Sc.¼ 4 transplants had similar donor characteristics, with
the exception of DUAL transplant donors being older
compared with the other two categories (Table 1). The
histological score distribution is reported in Figure 1. KDPI
distribution in each group is reported in Figure 2 and in
Table 1. STANDARD transplants had a uniform distribution
across all KDPI values up to the value of 73, abovewhich no
STANDARD transplant occurred (Figure 2). About 75% of
STANDARD transplants had KDPI below 50. Conversely,
66% of DUAL transplants, and about 40% of SINGLE
Sc.< 4 and SINGLE Sc.¼ 4, had a KDPI between 91 and
100 (Table 1). The median KDPI (IQR) was 36 (18–51), 93
(86–96), 87 (76–93) and 87 (78–94) in STANDARD, DUAL,
SINGLE Sc.<4 and SINGLE Sc.¼ 4, respectively.
Recipient characteristics: Compared with STANDARD
transplants, recipients of marginal transplants (DUAL,
SINGLE Sc.<4, SINGLE Sc.¼ 4) were older (Table 2).
Recipients of STANDARD transplantswere also better HLA
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matched than those of DUAL transplants, but the re-
transplants were more frequent in STANDARD than in
DUAL transplantation. DUAL transplant recipients had the
shortest waiting time on dialysis.
Graft survival
After a median follow-up of 3.3 years (IQR: 2.0–5.0 years),
47 patients died with a functioning graft and 69 returned to
dialysis.
Uncensored graft survival was similar between STANDARD
andpooledmarginal transplants (hazard ratio [HR]: 1.20 [95%
CI: 0.80–1.79; p¼ 0.38]). However, compared to STAN-
DARD transplants, uncensored graft survival was similar in
DUAL transplants (p¼0.98), whereas it was lower in
SINGLE Sc.<4 (p¼0.013) and SINGLE Sc.¼ 4 (p< 0.001)
(Figure 3A). SINGLE Sc.¼4 had also inferior uncensored
graft survival compared to SINGLE Sc.< 4 (p¼0.033).
In the analyses stratified by type of transplant, for every 10-
point increase in KDPI, the HR of graft failure was 1.12
(95%CI: 0.97–1.26; p¼ 0.053). The relationship between
KDPI and graft failure did not significantly change according
to the type of transplant (p¼ 0.61, for interaction between
KDPI and type of transplant). Even after adjustment for
KDPI, SINGLE Sc.¼4 remained the category with the
lowest graft survival (HR¼2.08 [p¼ 0.086], HR¼ 3.63
[p¼ 0.003], HR¼1.93 [p¼ 0.028] vs. STANDARD, DUAL
and SINGLE Sc.< 4, respectively). Results were similar
after additional adjusting for recipient characteristics (data
not shown). Covariate-adjusted predicted 1-, and 3-year
survival for a hypothetical donorwith KDPI¼ 98was 95.2%
(95%CI: 90.3–97.7) and 91.7% (95%CI: 83.7–95.9) in
DUAL, 91.2% (95%CI: 87.1–94.1) and 85.0% (95%CI:
79.0–89.4) in SINGLE Sc.< 4, and 83.6% (95%CI:
72.9–90.4) and 72.9% (95%CI: 57.5–83.4) in SINGLE
Sc.¼ 4, respectively.
Table 1: Donor characteristics
All
STANDARD
(no PTDB)
Marginal
p-ValueDUAL
SINGLE
Sc.<4
SINGLE
Sc.¼4
N 690 248 102 278 62
Age, years 56.1 (16.7) 39.3 (13.0) 68.7(8.4) 64.0 (10.6) 65.8 (9.6) <0.0011,2,3,4
Male gender, % 65.7 61.3 70.6 67.6 71.0 0.23
Diabetes, % 8.1 1.2 10.8 12.9 11.3 <0.0011,2,3
Hypertension, % 39.7 9.3 53.9 55.8 62.9 <0.0011,2,3
eCrCl, mL/min 89.1 (35.4) 112.4 (4.4) 71.9 (21.4) 78.0 (25.1) 73.9 (21.4) <0.0011,2,3
eCrCL 30–59, % 16.6 3.2 28.3 22.8 22.9 <0.0011,2,3
eCrCL<30, % 0.4 1.2 0.0 0.0 0.0 0.27
eGFR, mL/min/1.73 m2 95.4 (35.7) 107.0 (40.3) 87.4 (26.6) 89.9 (33.0) 85.1 (25.8) <0.0011,2,3
eGFR 30–59, % 10.4 3.2 14.0 13.8 16.4 <0.0011,2,3
eGFR<30, % 1.0 1.6 0.0 1.1 0.0 0.71
CV death, % 63.5 43.6 79.2 73.7 61.3 <0.0011,2
Weight, kg 74.0 (13.4) 73.0 (15.1) 73.7 (13.3) 74.7 (12.5) 76.3 (11.3) 0.28
Height, cm 169.2 (9.0) 171.0 (10.1) 167.7 (8.0) 168.4 (8.3) 168.9 (8.5) 0.0021,2
BMI, kg/m2 25.8 (4.1) 24.9 (4.5) 26.2 (4.0) 26.3 (3.8) 26.8 (3.5) <0.0011,2,3
Obesity, % 9.0 7.7 9.0 11.1 6.6 0.52
CIT, hours 16.4 (5.5) 14.8 (6.4) 17.8 (4.1) 17.2 (5.0) 17.9 (5.0) <0.0011,2,3
ECD donor, % 52.2 0.0 85.0 78.0 88.5 <0.0011,2,3
KDRI 1.32 (0.44) 0.86 (0.18) 1.70 (0.31) 1.53 (0.32) 1.57 (0.34) <0.0011,2,3,4
KDPI 66.6 (29.6) 35.0 (19.2) 89.3 (9.9) 82.6 (15.1) 83.9 (15.2) <0.0011,2,3,4
KDPI 80–90, % 16.5 0.0 18.6 25.7 32.8 <0.0011,2,3
KDPI 91–100, % 29.7 0.0 66.0 41.8 39.3 <0.0011,2,3,4,5
CIT, cold ischemia time; CV death, cerebrovascular death; DUAL, dual kidney transplant; ECD, expanded criteria donor; eGFR, estimated
GFR (MDRD formula); eCrCl, estimated creatinine clearance (Cockroft-Gault); KDPI, Kidney Donor Profile Index (see text); KDRI, Kidney
Donor Risk Index (see text); PTDB, pretransplant donor biopsy; SINGLE Sc.<4, single kidney transplant with PTDB yielding a score<4;
SINGLE Sc.¼4, single kidney transplant with PTDB yielding a score¼4; STANDARD, standard criteria donor kidney transplant.
Continuous data are reported as mean (standard deviation), categorical data as percentages.
Superscript letters indicate p<0.01 for pairwise comparisons as follows:
1STANDARD versus DUAL.
2STANDARD versus SINGLE Sc.<4.
3STANDARD versus SINGLE Sc.¼4.
4DUAL versus SINGLE Sc.<4.
5DUAL versus SINGLE Sc.¼4.
6SINGLE Sc.<4 versus SINGLE Sc.¼4.
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These results were roughlymirrored by the death-censored
analysis. SINGLE Sc.¼ 4 transplants had lower death-
censored graft survival compared to STANDARD transplant
(p¼0.008) and also, at a borderline significance level,
compared to DUAL transplants (p¼0.053) and SINGLE
Sc.< 4 (p¼0.083) (Figure 3B). Indeed, even after adjust-
ment for KDPI, SINGLE Sc.¼ 4 remained the category with
the lowest death-censored graft survival (HR¼ 1.86
[p¼0.26], HR¼ 2.85 [p¼0.048], HR¼2.05 [p¼ 0.067]
vs. STANDARD, DUAL and SINGLE Sc.< 4, respectively).
Similar findings were obtained after additional adjustment
for recipient characteristics (not shown).
Renal graft function
Figure 4 shows crude average eGFR at each time point in
grafts surviving beyond 3 months posttransplantation. To
Figure 1: Histological score distribution in the different types
of kidney transplants. Histological score distribution of both
kidneys in DUAL, SINGLE Sc.<4 and SINGLE Sc.¼4 transplants
are shown in the upper, medium and lower panels, respectively.
There were 8/102 DUAL transplants (7.8%) from donors with a
total score<8: they were usually donors with severe ultrasound
abnormalities (e.g. huge and multiple cysts) casting doubts on the
real amount of viable renal parenchyma; there were also 13/278
SINGLE Sc.<4 transplants (4.7%) and 18/62 SINGLE Sc.¼4
transplants (29.0%) from donors receiving a total score of 7: they
were instances in which one kidney was scored¼4 and the other
kidney¼3 and both kidneys were allocated as single transplants
(the numbers 13 and 18 do not match since not all kidneys were
eventually transplanted because of technical problems or
exchanges with other Organ Procurement Organizations); there
were 3/278 SINGLE Sc.<4 transplants (1.1%) from donor
receiving a total score>7: they were cases in which the
contralateral kidney had been discarded; finally, there were 4/62
SINGLE Sc.¼4 (6.5%) transplants from donor receiving a total
score<7: they were instances in which the contralateral kidney
received a score2. DUAL, dual kidney transplant; SINGLE
Sc.<4, single kidney transplant with pretransplant donor biopsy
score<4; SINGLE Sc.¼4, single kidney transplant with
pretransplant donor biopsy score¼4; STANDARD, standard
criteria donor kidney transplant.
Figure 2: KDPI distribution in the different type of kidney
transplants. STANDARD transplants showed a uniform
distribution across all KDPI values up to the value of 73, above
which no STANDARD transplant occurred. The marginal kidneys
had a left-skewed distribution, with the most KDPI values ranging
between 85 and 100. KDPI, Kidney Donor Profile Index;
STANDARD, standard criteria donor kidney transplant.
Biopsy-Based Allocation of High KDPI Donors
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allow for unbalanced data, we used mixed models for
repeated measurements and reported the results in
Table 3, which shows the estimate of 1-year eGFR
and the average eGFR slope (i.e. yearly linear decline in
eGFR levels) in each group. Because the slope did not
differ between groups (p¼0.22) in either the crude or
the adjusted analyses, the between-group difference in
eGFR can be regarded as constant at each time point of
follow-up.
Compared to STANDARD transplants, unadjusted 1-year
eGFR was 9.3mL/min/1.73 m2 (95% CI: 13.6 to 5.0;
p< 0.001), 17.9mL/min/1.73 m2 (95% CI: 21.0 to
14.7; p< 0.001) and 18.8mL/min/1.73 m2 (95% CI:
24.2 to 13.4; p<0.001) lower in DUAL, in SINGLE
Sc.< 4, and in SINGLE Sc.¼ 4 transplants, respectively
(DUAL compared to SINGLE Sc.< 4 and SINGLE Sc.¼ 4
transplants: p< 0.001 and p¼ 0.002, respectively; SINGLE
Sc.< 4 vs. SINGLE Sc.¼ 4: p¼0.74).
Table 2: Recipient characteristics
All
STANDARD
(no PTDB)
Marginal
p-ValueDUAL SINGLE Sc.<4 SINGLE Sc.¼4
N 690 248 102 278 62
Age, years 52.9 (12.1) 42.7 (11.0) 61.7 (4.8) 57.5 (9.4) 57.9 (8.6) <0.0011,2,3,4
Male gender, % 65.7 61.3 70.6 67.6 71.0 0.23
Hypertension, % 74.6 66.1 83.2 79.1 69.3 0.0011,2
Diabetes, % 5.9 6.0 1.0 6.5 8.1 0.091
Obesity, % 4.3 4.8 1.0 5.5 1.6 0.18
BMI, kg/m2 24.2 (3.2) 23.7 (3.4) 24.8 (2.7) 24.6 (3.2) 23.8 (3.1) 0.0021,2
Retransplant, % 8.4 13.7 1.0 7.2 4.8 <0.0011
Dialytic, age 4.5 (3.4) 4.8 (3.8) 3.6 (2.6) 4.6 (3.4) 4.6 (2.8) 0.0171,4
>4 years 39.9 44.3 29.4 39.0 45.1 0.054
HCV status, % 9.0 10.9 5.9 9.4 8.1 0.55
CMV status
DþRþ, % 76.1 70.5 78.6 77.4 74.6 0.44
DþR, % 9.5 6.8 12.7 10.4 12.9 0.20
DRþ, % 6.4 6.4 4.9 6.8 6.4 0.95
DR, % 3.8 2.5 3.1 4.5 3.6 0.83
PRA>20%, % 18.3 21.7 17.2 19.1 11.3 0.33
HLA mm level 2.8 (0.7) 2.8 (0.7) 3.0 (0.8) 2.8 (0.7) 2.9 (0.6) 0.021
HLA mm level¼4, % 17.6 12.9 30.4 17.3 16.1 0.0021,4
Primary disease
Hypertension, % 11.9 7.7 18.6 12.6 8.1 0.021
Diabetes, % 2.9 2.8 0.0 1.8 3.2 0.28
ADPKD, % 15.9 12.9 12.7 19.1 17.7 0.19
Glomerulonephritis, % 30.9 32.3 39.2 27.8 29.0 0.19
Others, % 39.3 44.3 29.4 38.6 41.9 0.069
Thymoglobulins, % 16.9 20.2 22.5 13.4 9.7 0.029
Basiliximab, % 74.0 71.8 66.7 76.9 82.3 0.078
Tacrolimus, % 48.4 60.9 47.5 37.5 47.5 <0.0012
Cyclosporine, % 51.1 39.1 52.5 61.0 51.1 <0.0012
MPA, % 70.5 68.5 75.2 68.8 70.5 0.64
mTOR-i, % 20.3 23.0 21.8 19.5 20.8 0.63
Steroid withdrawal, % 7.5 3.6 7.8 10.1 9.8 0.0212
ADPKD, adult dominant polycystic kidney disease; CMV, cytomegalovirus; D, donor and R, recipient positive (þ), or negative() CMV
serostatus; DUAL, dual kidney transplant; HCV, hepatitis C virus; HLAmm level [see ref. 29]; MPA, mycophenolate acid (-mofetil or enteric
coated sodium); mTOR-I, mTOR inhibitors (sirolimus or everolimus); PRA, panel reactive antibody; PTDB, pretransplant donor biopsy;
SINGLE Sc.<4, single kidney transplant with PTDB yielding a score<4; SINGLE Sc.¼4, single kidney transplant with PTDB yielding a
score¼4; STANDARD, standard criteria donor kidney transplant.
Continuous data are reported as mean (standard deviation), categorical data as percentages.
Superscript letters indicate p<0.01 for pairwise comparisons as follows:
1STANDARD versus DUAL.
2STANDARD versus SINGLE Sc.<4.
3STANDARD versus SINGLE Sc.¼4.
4DUAL versus SINGLE Sc.<4.
5DUAL versus SINGLE Sc.¼4.
6SINGLE Sc.<4 versus SINGLE Sc.¼4.
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The relationship between KDPI and eGFR differed accord-
ing to the type of transplant. Indeed, there was a significant
association between KDPI and 1-year eGFR in STANDARD
(p<0.001), DUAL (p< 0.001) and SINGLE transplants
Sc.< 4 (p< 0.001), but no association in SINGLE Sc.¼ 4
transplants (p¼0.55) (Figure 5 and Table 4). For every 10-
point increase in KDPI, 1-year eGFR decreased approxi-
mately 4mL/min/1.73 m2 in STANDARD transplant
(p<0.001), 6mL/min/1.73 m2 in DUAL transplants
(p<0.001) and 3mL/min/1.73 m2 in SINGLE Sc.< 4
transplants (p< 0.001) (Figure 5 and Table 4). Because
there were virtually no STANDARD transplants with
KDPI> 70 (Figure 2), the relationship between KDPI and
1-year eGFR for KDPI values above 70 in STANDARD
transplants must be regarded as artificial extrapolation.
Table 4 reports actual KDPI (median and IQR) in the study
population to allow for a better appraisal of the extent that
these findings be translated into meaningful differences in
real life conditions.
Covariate-adjusted predicted 1-year eGFR for a hypothetical
donor with KDPI¼98 was 45.1mL/min/1.73 m2 (95%CI:
40.9–49.3) in DUAL, 39.4mL/min/1.73 m2 (95%CI: 36.6–
42.2) in SINGLE Sc.< 4, and 42.6mL/min/1.73 m2 (95%CI:
37.0–48.2) in SINGLE Sc.¼4, respectively.
Delayed graft function, acute rejection, proteinuria
and hypertension
STANDARD transplants had the lowest incidence of
delayed graft function, whereas the incidence of acute
rejection was similar across the groups (Table 5).
After 1 year of follow-up, the estimated prevalence of
proteinuria, adjusted for KDPI and recipient risk factors,was
15.5% (95%CI: 9.8–21.3), 19.8% (95%CI: 12.8–26.7),
28.8% (95%CI: 23.0–34.7) and 42.1% (95%CI: 30.0–
54.3) in STANDARD, DUAL, in SINGLE Sc.< 4 and in
SINGLE Sc.¼ 4 transplants, respectively. Apart from the
comparison between STANDARD and DUAL transplants,
all the prevalence estimates differed statistically from each
other (p<0.05 for the pairwise comparisons). Covariate-
adjusted predicted 1-year prevalence of proteinuria for a
hypothetical donor with KDPI¼ 98 was 26.0% (95%CI:
17.8–34.3) in DUAL, 37.5% (95%CI: 30.9–44.2), in SINGLE
Sc< 4 and 52.9% (95%CI: 40.0–65.8) in SINGLE Sc.¼ 4
transplants, respectively.
Average systolic and diastolic blood pressure (at 1-year
follow-up: 13415.3 and 80.17.7mmHg, respectively),
Figure 3: Graft survival in the four categories of kidney
transplant. Panel A, uncensored graft survival. The log-rank test
reported on the plot refers to the test for any difference between
the four types of transplants. Compared to STANDARD
transplants, uncensored crude graft survival was similar in DUAL
transplants (p¼0.98), whereas it was lower in SINGLE Sc.<4
(p¼0.013) and SINGLE Sc.¼4 (p<0.001). SINGLE Sc.¼4 had
also inferior uncensored graft survival compared to SINGLE Sc.<4
(p¼0.033). Panel B, death-censored graft survival. DUAL, dual
kidney transplant; SINGLE Sc.<4, single kidney transplant with
pretransplant donor biopsy score<4; SINGLE Sc.¼4, single
kidney transplant with pretransplant donor biopsy score¼4;
STANDARD, standard criteria donor kidney transplant.
Figure 4: eGFR changes over follow-up period. Crude marginal
means (dots) and standard deviation (bars) of the eGFR in the four
groups among grafts surviving beyond month 3
posttransplantation. DUAL, dual kidney transplant; eGFR,
estimated GFR; SINGLE Sc.<4, single kidney transplant with
pretransplant donor biopsy score<4; SINGLE Sc.¼4, single
kidney transplant with pretransplant donor biopsy score¼4;
STANDARD, standard criteria donor kidney transplant.
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did not differ between groups. However, adjusted analyses
showed a significant association between KDPI and blood
pressure: for a 10-point KDPI increase, systolic blood
pressure was þ1.0mmHg higher (95%CI: þ0.3 to 1.6;
p¼ 0.003), and diastolic blood pressure was þ0.5mmHg
higher (95%CI: þ0.2 to þ0.8; p¼ 0.002).
Discussion
We newly demonstrate that allocating marginal kidneys
with KDPI in the highest range, to single or dual
transplantation on the basis of the findings of a standardized
and highly reproducible (30) PTDB assessment is associat-
ed with excellent outcomes and minimal discard rates.
By using the KDPI score, our report allows comparison of
the present findings with those of future studies. In
particular, our results compare favorably with those of a
recent analysis of the OPTN/UNOS Registry (4), showing
that discard rates for kidneys with KDPI between 80–90%
and 90–100% are 36.3% and 62.5%, respectively,
compared to only 14.9% and 36.8% in the present study.
Thus, a PTDB-based allocation system of marginal kidneys
halves the relative discard rate and allows a>25% absolute
increase in the rate of recovery of kidneys with KDPI >80.
Even taking into account that approximately 20% of these
organs are transplanted in couple,we estimate that a PTDB-
based strategy increases the number of kidney transplants
from donors with a KDPI of 80–100 by above 20%, which
corresponds to an overall increase in transplantation of
approximately 4% considering the entire donor pool.
Our study confirms and expands previous evidence that
histological criteria for allocation of marginal kidneys to
single transplantation can bewidened to include grafts with
a score of 4 (31–33). Since those grafts represented almost
20% of the kidneys that underwent pretransplant biopsy
evaluation in our cohort, our results could have major
implications in further expanding the pool of available
donors. SINGLE Sc.¼ 4 transplants, however, showed
inferior graft survival than the other categories of marginal
kidneys and increased rates of proteinuria, raising a note of
caution in allocating these kidneys to recipients with longer
life expectancies
Table 3: Estimated 1-year eGFR and eGFR slope in each group
STANDARD DUAL SINGLE Sc.<4 SINGLE Sc.¼4 p-Value
1-year eGFR, mL/min/1.73 m2 60.9 51.1 43.6 43.8 p<0.0011,2,3,4,5,6
95% CI 59.7 to 63.1 48.1 to 54.9 41.5 to 45.7 39.2 to 48.4
eGFR slope, mL/min/1.73 m2/year 0.06 0.01 þ0.04 þ0.13 p¼0.22
95% CI 0.11 to 0.02 0.11 to þ0.09 0.03 to þ0.10 0.01 to þ0.26
p-Value p¼0.008 p¼0.81 p¼0.29 p¼0.063
DUAL, dual kidney transplant; eGFR, estimated GFR; slope, yearly change of eGFR; SINGLE Sc.<4, single kidney transplant with
pretransplant donor biopsy yielding a score<4; SINGLE Sc.¼4, single kidney transplant with pretransplant donor biopsy yielding a
score¼4; STANDARD, standard criteria donor kidney transplant; 95% CI, 95% confidence interval.
p-Values in the rightmost column refer to the test of any difference between groups in average 1-year eGFR and eGFR slope, respectively.
Superscript letters indicate p<0.01 for pairwise comparisons as follows:
1STANDARD versus DUAL.
2STANDARD versus SINGLE Sc.<4.
3STANDARD versus SINGLE Sc.¼4.
4DUAL versus SINGLE Sc.<4.
5DUAL versus SINGLE Sc.¼4.
6SINGLE Sc.<4 versus SINGLE Sc.¼4.
Figure 5: Predicted relationship between KDPI and 1-year
eGFR in each category. The relationship between KDPI and 1-year
eGFR was significant in STANDARD (p<0.001), DUAL (p<0.001)
and SINGLE Sc.<4 (p<0.001) transplants, but it was not
significant in SINGLE Sc.¼4 transplants (p¼0.55). Because
there were virtually no STANDARD transplants with KDPI>70
(see Figure 2), the relationship between KDPI and 1-year eGFR for
KDPI values above 70 in STANDARD transplantsmust be regarded
as an artificial extrapolation. DUAL, dual kidney transplant; SINGLE
Sc.<4, single kidney transplant with pretransplant donor biopsy
score<4; SINGLE Sc.¼4, single kidney transplant with
pretransplant donor biopsy score¼4; STANDARD, standard
criteria donor kidney transplant; 1-year eGFR, estimated GFR at
1 year posttransplant.
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One may speculate that the implementation of a KDPI-
based allocation algorithm might further increase discard
rates of kidneys from marginal deceased donors, as
some centers may not accept donors with extremely high
KDPI values. As such, our findings suggest that a biopsy
report supporting the suitability of the graft despite the
high KDPI value (even for KDPI close to 100) could be
important in reassuring transplant centers about the organ
quality.
We acknowledge that a standardized PTDB assessment is
logistically demanding, and the challenges of having kidney
biopsies processed, properly stained and examined on
short notice (e.g. within 3–4 h) by an on-call, centralized
pathology service (34) are significant. However, in consid-
eration of its substantial impact in terms of kidney recovery,
this option should be seriously considered.
A potential way to shorten the time of biopsy processing
and partially ease the wider implementation of PTDB is the
use of frozen sections to assess the organ quality, but
studies assessing whether this approach is as informative
as the standardized evaluation of formalin-fixed stained
sections are lacking.
Table 4: Relation between KDPI and 1-year eGFR in each group
STANDARD DUAL SINGLE Sc.<4 SINGLE Sc.¼4 p-Value
KDPI median 36 93 87 87
[IQR] [18–51] [86–96] [76–93] [78–94]
Crude difference
in 1-year eGFR
per 10-point
increase in KDPI,
mL/min/1.73 m2/year
4.3 5.8 2.8 0.8 p¼0.0272,3,4,5
95% CI 5.4 to 3.3 9.0 to 2.6 4.1 to 1.6 3.5 to þ1.9
p-Value p<0.001 p<0.001 p<0.001 p¼0.55
Adjusted difference
in 1-year eGFR per
10-point increase in
KDPI, mL/min/1.73 m2/year
3.9 6.4 2.6 0.6 p¼0.0163,4,5
95% CI 5.1 to 2.7 9.5 to 3.2 4.0 to 1.3 3.3 to þ2.0
p-Value p<0.001 p<0.001 p<0.001 p¼0.64
DUAL, dual kidney transplant; eGFR, estimated GFR; IQR, interquartile range; KDPI, Kidney Donor Profile Index (see text); SINGLE Sc.<4,
single kidney transplant with pretransplant donor biopsy yielding a score<4; SINGLE Sc.¼4, single kidney transplant with pretransplant
donor biopsy yielding a score¼4; STANDARD, standard criteria donor kidney transplant; 95% CI, 95% confidence interval.
p-Values in the rightmost column refer to the test of any difference between groups in the relation between KDPI and 1-year eGFR.
Superscript letters indicate p<0.10 for pairwise comparisons in crude analysis, and p<0.05 in adjusted analysis as follows:
1STANDARD versus DUAL.
2STANDARD versus SINGLE Sc.<4.
3STANDARD versus SINGLE Sc.¼4.
4DUAL versus SINGLE Sc.<4.
5DUAL versus SINGLE Sc.¼4.
6SINGLE Sc.<4 versus SINGLE Sc.¼4.
Table 5: Incidence of delayed graft function and acute rejection in each group
STANDARD DUAL SINGLE Sc.<4 SINGLE Sc.¼4 p-Value
Delayed graft function 25.4 38.0 37.2 31.7 p¼0.0202
Acute rejection 15.1 10.8 15.5 9.7 p¼0.51
DUAL, dual kidney transplant; SINGLESc.<4, single kidney transplantwith pretransplant donor biopsy yielding a score<4; SINGLESc.¼4,
single kidney transplant with pretransplant donor biopsy yielding a score¼4; STANDARD, standard criteria donor kidney transplant.
Numbers refer to percentages.
p-Values in the rightmost column refer to the test of any difference between groups. Superscript letters indicate p<0.01 for pairwise
comparisons as follows:
1STANDARD versus DUAL.
2STANDARD versus SINGLE Sc.<4.
3STANDARD versus SINGLE Sc.¼4.
4DUAL versus SINGLE Sc.<4.
5DUAL versus SINGLE Sc.¼4.
6SINGLE Sc.<4 versus SINGLE Sc.¼4.
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To the best of our knowledge, we included the largest
retrospective series of marginal kidney transplants evaluat-
ed by standardized PTDBever published.Our findings could
be affected by the different factors involved in the allocation
algorithm in each country. Nonetheless, our results are
more generalizable than those of most previous studies,
because we based our analyses on KDPI, allowing us to
compare donor quality across different cohorts, and the
Remuzzi score, which has been consistently associated
with graft outcomes (18). However, prospective studies are
needed to confirm our findings on the effect of PTDB on
discard rates, and outcomes. Moreover, our work shares
the same bias of every other previous study, that is, that
recipients of dual kidney transplants had no aorto-iliac
and coronary artery disease and were in better general
condition than recipients of single transplants, which could
explain their excellent outcomes. Althoughwe, unlikemost
of the previous studies, adjusted the analyses for recipients
characteristics, we cannot exclude that our findings were
affected by residual confounding.
In conclusion, our study provides evidence that standard-
ized PTDBassessment allows recovering kidneyswith poor
KDPI values, without compromising graft outcomes. These
findings are important in the context of attempting to
reduce the high discard rates of marginal kidneys in the
United States.
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